Miami, FL, United States of America

Roberta Brambilla

USPTO Granted Patents = 2 

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2020-2021

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Roberta Brambilla: Innovator in Medical Treatments

Introduction

Roberta Brambilla is a distinguished inventor based in Miami, FL (US). She has made significant contributions to the field of medical treatments, particularly in the area of lung inflammation and multiple sclerosis. With a total of 2 patents, her work is paving the way for innovative therapeutic approaches.

Latest Patents

Roberta's latest patents include "Methods for treating lung inflammation with an anti-ASC antibody." This patent describes compositions and methods that involve agents inhibiting inflammasome signaling in mammals. These agents include antibodies directed against inflammasome components, which can be used alone or in combination with extracellular vesicle uptake inhibitors. Additionally, she has developed "Methods and compositions for treating multiple sclerosis," which also focuses on agents that inhibit inflammasome signaling, showcasing her commitment to addressing critical health issues.

Career Highlights

Roberta Brambilla is affiliated with the University of Miami, where she continues her research and development in medical innovations. Her work is characterized by a strong focus on improving treatment options for patients suffering from serious conditions.

Collaborations

Some of her notable coworkers include Robert W. Keane and W. Dalton Dietrich, who contribute to her research endeavors and help advance her innovative projects.

Conclusion

Roberta Brambilla's contributions to medical science through her patents and research at the University of Miami highlight her role as a leading inventor in the field. Her work is essential for developing new treatments that can significantly improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…